Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 28, 2017 – The FDA approved Genentech’s Ocrevus (ocrelizumab) for the treatment of adult patients with relapsing or primary progressive forms of multiple sclerosis (MS).
Return to publications